Arthroscopic Technologies
Launching February 2021
SmartTRAK is expanding its Sports Medicine coverage, covering arthroscopic enabling technologies and devices including:- Visualization
- Mechanical resection
- Radio frequency ablation
- Fluid management
By Thomas Wallick on 2/2/21 8:00 AM
By Thomas Wallick on 1/21/21 9:30 AM
We are pleased to announce that Jenny Blair, MD, has joined the team at SmartTRAK as Senior Analyst/Editor. Jenny has 10+ years' experience as an award-winning journalist and analyst. Formerly a board-certified emergency physician, Jenny has provided coverage of device markets for Medtech Insight and contributed to Univadis, Medscape, MedPage Today and Discover.
Meet Jenny Blair:What is your role with SmartTRAK? I’m a Senior Analyst/Editor helping to cover Neuro Therapies and Digital/CAS and providing occasional editorial and analyst support across all modules and product lines.
What do you like about SmartTRAK? The interface is clean, inviting, and information-rich.
What is something special or unique that you bring to SmartTRAK subscribers? I’m an unusual creature—a science and medical writer and journalist as well as a former emergency physician. So I’m at home speaking with and synthesizing information from a variety of experts while also knowing firsthand about some of the challenges clinicians face.
By Sharon O'Reilly on 1/11/21 10:00 AM
2020 was a tumultuous year like no other, and SmartTRAK, the leading provider of real-time market data, analysis and advisory services for the orthopedic, wound, regenerative medicine and neuro therapies markets, was here to keep you informed of everything that transpired in the MedTech industry. SmartTRAK covered all the key happenings in 2020, providing comprehensive industry coverage of the latest trends, news, intel and interviews most important to you.
Here are SmartTRAK 's Top 10 blog posts of the past year with 3 bonus posts, because at SmartTRAK we always strive to deliver more than what's expected!
1) A Critical Crossroads for COVID-19: An Interview with Krishnan Chakravarthy
by Anne Staylor, 3/23/20
Krishnan Chakravarthy, MD, PhD discusses the COVID-19 pandemic, current and evolving methods for containing and treating the virus, how it's changing the practice of pain medicine and its impact on industry in an interview with SmartTRAK.
2) Europe: New Routines in Greetings and in Wound Management
by Anikó Szekér, 12/21/20
SmartTRAK examines the Top 5 countries in Europe during the time of COVID-19 and estimates how the Advanced Wound Dressing Market will be impacted in 2020 and 2021.
3) What's New in Spine and Orthopedic Computer-Assisted Surgery (CAS)
by Elise Wolf, 11/24/20
SmartTRAK highlights what’s new in the Spine and Orthopedic Computer-Assisted Surgery (CAS) markets.
By Thomas Wallick on 10/19/20 9:34 AM
We are pleased to announce that Matt Golembeski has joined the team at SmartTRAK as Director of Sales. Matt has 15+ of sales and sales management experience in the medical device industry with a concentration in spine and spine-supportive technologies.
By Thomas Wallick on 9/18/20 9:30 AM
We are pleased to announce that Tim Patrick has joined the team at SmartTRAK as Senior Manager of Corporate Accounts. Tim has 5+ years experience in Medical Device Sales and Healthcare IT. Tim had prior roles at Zimmer Biomet and Abbott Laboratories.
Meet Tim Patrick:
What is your role with SmartTRAK? I’ve joined the commercial team as a Senior Manager of Corporate Accounts.
What do you like about SmartTRAK? It’s tough to keep this question to a paragraph, but I will do my best! The space, product and people are what really intrigues me about SmartTRAK. The Medtech/Software space is ever changing and as dynamic of a space that I’ve been involved with. The product is absolutely incredible. The type of data we provide at your fingertips is a must have. Lastly, I’ve come from large Fortune 500 companies who have claimed to be a tight knit team but nothing compares to what we currently have at SmartTRAK. From the other reps, analysts, and up to the CEO it truly is the best culture I have ever been a part of.
By Thomas Wallick on 8/4/20 8:40 AM
In the pharmacies in Russia, commercial drug June sales increased by 0.1% in value vs May 2020. Compared to June 2019, sales increased by 2.1%. The increase in the first 6 mos in 2020 was 13.9% vs the same period in 2019.
During the lockdown in April, 27% of all consultations were teleconsultations in France. Of doctors carrying out teleconsultations, 50% were under 50 yrs old, though that age group represents only 37% of all GPs.
MedTech companies in Germany expect sales to decline an avg of 8% in 2020 due to the pandemic, including 12% in int’l business according to a survey. Almost 60% of companies expect a double-digit drop.
By Thomas Wallick on 7/24/20 1:18 PM
SmartTRAK, the leading source of competitive intelligence used by the top global orthopedic & wound care companies, had four articles featured in the International Cartilage Regeneration & Joint Preservation Society Summer 2020 Issue. These articles were originally published on the SmartTRAK platform.
The ICRS is the main forum for international collaboration in cartilaginous tissue research and joint preservation whose stated mission is "Advancing Science & Education of the Prevention & Treatment of Cartilage Disease Worldwide."
Kim French, SmartTRAK's Senior Analyst, OrthoBio, had three of her articles included in the Summer 2020 issue:
By Thomas Wallick on 7/20/20 1:40 PM
As the COVID-19 pandemic progresses and continues to affect everyday life around the world, the path that lies ahead for the MedTech industry and the search for effective therapeutics and vaccines remains hard to predict.
The following is a small sampling of the updates compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.
With 4 of the leading vaccine candidates expected to enter Phase 3 studies in July (Sinovac, Moderna, BioNTech/PFE, CanSino), Phase 2 data could be reported in summer/fall 2020. If +, WFS says it could be a catalyst for some medtech sectors in recovery of elective procedures.
A survey assessing public perceptions towards resuming elective surg found out of 722 people 61% were concerned w/ contracting COVID-19 during surg. Overall, 57% would have surgery at a hospital vs outpatient and 27% would undergo surg in the first mo of reopening. J Arthroplasty
The European Commission published a document about the preparedness of health systems in Europe for future COVID-19 outbreaks. Topics comprise testing, contact tracing, surveillance, accessibility of medical devices and capacity measures.
By Thomas Wallick on 7/6/20 4:35 PM
As COVID-19 surges in the United States and around the world, health officials are responding with stern warnings, more testing and cutbacks on closings. While some nations have virtually stopped the spread within their country, MedTech prepares for a post-COVID world and how the virus and the response to it will reshape the industry.
The following is a small sampling of the COVID-19 updates compiled, reviewed and posted in real-time by our SmartTRAK analysts, who are constantly monitoring the situation and sifting through the noise to present the most relevant news to our subscribers:
A statistical analysis study concluded elective procedure deferment during the COVID-19 pandemic will have a lasting impact on the US healthcare system and could result in a cumulative backlog of > 1MM ortho surgical cases at 2 years after the end of surgery deferment. JBJS
A report w/ the title of ”Getting the NHS back on track: planning for the next phase of COVID-19” was published in the UK by the NHS Confederation. The paper talks about the 7 challenges of the health care system when restarting the health care services in the UK.
Canaccord feels SNN’s Q220 preliminary results suggest better-than-expected improvements and an upside to H220 estimates. Canaccord feels US states/health systems are better positioned to handle COVID cases and doesn’t expect widespread elective procedure restrictions.
By Thomas Wallick on 6/29/20 9:18 AM
As the international response to COVID-19 shifts to preparing for a potential second wave, the Medtech industry pushes forward with the development and approval of new devices. The following is just a small sampling of the past week's international updates that were curated, compiled, reviewed and posted throughout the day by the expert analysts at SmartTRAK. They sift through the noise to discover the latest international news, industry trends, financial data and competitor developments in the global Life Sciences industry.
In Germany, as a result of the past months, BVMed proposed to the Minister of Health to build stock for masks and protective equipment for 6 months to be used in pandemics.
The Odense University Hospital in Denmark built up a blended learning concept in wound care for nurses to support them in gaining confidence when carrying out wound care. E-learning modules, study visits and workshops are mixed to address the needs.
In France, The National Agency for the Safety of Medicines and Health Products (ANSM) published a guideline on how advertising visas should be handled for medical devices during the state of emergency (until July 10, 2020) and through the year.
Freight costs have increased dramatically during the COVID-19 outbreak. Chinese medical dressing export are mainly low cost, less advanced dressings. Manufacturers are now looking more to grow sales on their local China market, to replace imported more advanced dressings.
SmartTRAK is a comprehensive, easy-to-use, business intelligence solution that networks an entire organization with real-time market data and analysis, fostering an innovative and collaborative approach to market strategy while driving better decisions. SmartTRAK, used by leading orthopedic and wound care companies, transforms the delivery of healthcare business information into a cost-effective solution for life science corporations to increase proficiency, improve productivity and reduce cost.
© 2008-2019 BioMedGPS, LLC. All rights reserved.